Pages that link to "Q31599290"

The following pages link to Thalidomide for treatment of patients with chronic graft-versus-host disease. (Q31599290):

Displaying 27 items.

• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report (Q26827651) (← links)
• Treatment of chronic graft-versus-host disease in 2011 (Q26851433) (← links)
• Graft-versus-host disease: why have we not made more progress? (Q27012940) (← links)
• Thalidomide-induced severe neutropenia during treatment of multiple myeloma (Q33361034) (← links)
• Chronic graft-versus-host disease: Pathogenesis and clinical management. (Q33371639) (← links)
• Current issues in chronic graft-versus-host disease (Q33917187) (← links)
• Failure-free survival after initial systemic treatment of chronic graft-versus-host disease (Q34077787) (← links)
• Thalidomide in cancer treatment: a potential role in the elderly? (Q34597832) (← links)
• Have we made progress in the management of chronic graft-vs-host disease? (Q34644980) (← links)
• Treatment of chronic graft-versus-host disease: Past, present and future (Q35524687) (← links)
• A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease (Q35737769) (← links)
• Rituximab for steroid-refractory chronic graft-versus-host disease (Q35848933) (← links)
• Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study (Q36233448) (← links)
• Therapy of chronic graft-versus-host disease (Q37173479) (← links)
• Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. (Q37268970) (← links)
• Treatment and management of graft-versus-host disease: improving response and survival (Q37371836) (← links)
• Cutaneous graft-versus-host disease--clinical considerations and management (Q37989375) (← links)
• Therapeutic effects of thalidomide in hematologic disorders: a review (Q38121762) (← links)
• Prophylactic and therapeutic treatment of graft-versus-host disease in Japan (Q38416371) (← links)
• State-of-the-art acute and chronic GVHD treatment (Q38416376) (← links)
• A Canine Model of Chronic Graft-versus-Host Disease (Q38778387) (← links)
• Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience (Q39138108) (← links)
• Ibrutinib for chronic graft-versus-host disease after failure of prior therapy (Q46428638) (← links)
• Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling. (Q53681955) (← links)
• A phase II/III randomized, multicenter trial of prednisone/sirolimus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft--host disease: BMT CTN 0801 (Q59810122) (← links)
• Phase-1/-2 study of pomalidomide in chronic GvHD (Q86890944) (← links)
• Systemic Injection of Thalidomide Prevent and Attenuate Neuropathic Pain and Alleviate Neuroinflammatory Response in the Spinal Dorsal Horn (Q91830004) (← links)